ClinVar Miner

Submissions for variant NM_000090.4(COL3A1):c.3440_3466del (p.Pro1147_Gly1155del)

dbSNP: rs1576472890
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000809044 SCV000949181 likely pathogenic Ehlers-Danlos syndrome, type 4 2018-08-29 criteria provided, single submitter clinical testing This variant, c.3440_3466del, results in the deletion of 9 amino acid(s) of the COL3A1 protein (p.Pro1147_Gly1155del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). This variant has been observed in an individual affected with Ehlers-Danlos syndrome (PMID: 24922459). Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL3A1, missense variants at these glycine residues are significantly enriched in individuals with disease (PMID: 24922459, 25758994) compared to the general population (ExAC). This variant affects four Gly-Xaa-Yaa repeats and is therefore likely to be causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.